Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03277209
Title To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

ovary serous adenocarcinoma

pancreatic adenocarcinoma

colorectal adenocarcinoma

Therapies

Plerixafor

Age Groups: adult senior


No variant requirements are available.